Robyn Anderson, NP
Nurse Practitioner · San Antonio, TXNPI 1912447251
Payments from drug & device makers
Across 455 payments — averaging $23.32 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Amgen$2K
- Johnson & Johnson$2K
- AbbVie$2K
- UCB, Inc.$808
- Mallinckrodt Hospital Products Inc.$772
- Novartis$735
- plus $3K from 17 others
What the payments were for
- Food & beverage$10,43498%
- Education$1772%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Amgen(2 entities) | 109 | $2,485 |
| Johnson & Johnson(2 entities) | 67 | $1,654 |
| AbbVie | 72 | $1,513 |
| UCB, Inc. | 24 | $808 |
| Mallinckrodt Hospital Products Inc. | 30 | $772 |
| Novartis | 29 | $735 |
| Lilly USA, LLC | 34 | $596 |
| AstraZeneca | 24 | $514 |
| GSK | 13 | $357 |
| Genentech USA, Inc. | 16 | $286 |
| Sanofi | 3 | $228 |
| Radius Health, Inc. | 9 | $213 |
| Antares Pharma, Inc. | 4 | $67 |
| Octapharma USA, Inc. | 3 | $60 |
| E.r. Squibb & Sons, L.L.C. | 3 | $58 |
| ANI Pharmaceuticals, Inc. | 2 | $49 |
| Cumberland Pharmaceuticals, Inc. | 3 | $40 |
| IBSA Pharma Inc. | 3 | $35 |
| Pfizer | 2 | $35 |
| Boehringer Ingelheim | 2 | $32 |
| Aurinia Pharma U.S., Inc. | 1 | $27 |
| Boston Scientific | 1 | $25 |
| Ultragenyx Pharmaceutical Inc. | 1 | $24 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$10,611 in reported general payments places this provider in the 95th percentile of 5,422 nurse practitioner providers in Texas.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Hydroxychloroquine Sulfate | 176 | $6,068 |
| Mycophenolate Mofetil | 26 | $6,042 |
| ProgesteroneProgesterone, Micronized | 53 | $5,952 |
| Leucovorin Calcium | 57 | $3,779 |
| MethotrexateMethotrexate Sodium | 64 | $1,599 |
| Leflunomide | 18 | $1,051 |
| Sulfasalazine DrSulfasalazine | 28 | $1,024 |
| Sulfasalazine | 20 | $602 |
| Doxycycline Hyclate | 41 | $553 |
| Pilocarpine Hcl | 13 | $335 |
| Folic Acid | 14 | $293 |
| Estradiol | 16 | $167 |
| Levothyroxine Sodium | 26 | $79 |
| EuthyroxLevothyroxine Sodium | 13 | $0 |
Paid to pharmacies, not to this prescriber.
Other nurse practitioner in San Antonio
- Corrie BerkSan Antonio$155K
- Sonja BruneSan Antonio$51K
- Laura GalvanSan Antonio$32K
- Eduardo GonzalezSan Antonio$32K
- Roberta RomeroSan Antonio$26K
- Christopher GarciaSan Antonio$21K
- Jennifer ZavalaSan Antonio$17K
- Amy RivasSan Antonio$17K
- Erika SimpsonSan Antonio$16K
- Alexis WahlenSan Antonio$16K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.